Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible

Mariusz Grinholc1, Bozena Szramka, Julianna Kurlenda

  • 1Department of Biotechnology, Division of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Kladki 24, 80-822 Gdansk, Poland. grinholc@biotech.ug.gda.pl

Insights

Photodynamic inactivation (PDI) shows potential as an alternative therapy against Staphylococcus aureus. This study found PDI effectiveness varied by bacterial strain, with biofilm production potentially influencing outcomes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Photomedicine

Background:

  • Staphylococcus aureus is a significant cause of hospital-acquired infections, leading to severe conditions like sepsis and toxic-shock syndrome.
  • Antibiotic resistance in S. aureus presents major therapeutic challenges, necessitating alternative treatment strategies.
  • Photodynamic inactivation (PDI) is emerging as a promising alternative to conventional antibiotic therapy.

Purpose of the Study:

  • To evaluate the bactericidal efficacy of photodynamic inactivation (PDI) against clinical isolates of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) Staphylococcus aureus.
  • To investigate the influence of bacterial strain characteristics, such as biofilm production, on PDI treatment outcomes.

Main Methods:

  • Photodynamic inactivation was performed using protoporphyrin diarginate as a photosensitizer.
  • The study analyzed the PDI effect on 40 clinical MRSA and 40 MSSA strains isolated from hospitalized patients.
  • An ATCC strain (25904) was used as a reference control.

Main Results:

  • Photodynamic inactivation demonstrated a strain-dependent bactericidal effect, with reductions in viable bacterial counts ranging from 0 to 3 log(10) units.
  • A correlation was observed between the ability of S. aureus strains to produce biofilm and their varied responses to PDI.
  • The precise mechanism underlying the observed strain-dependent efficacy of PDI remains to be elucidated.

Conclusions:

  • Photodynamic inactivation is a potential therapeutic approach for treating infections caused by both MRSA and MSSA strains.
  • Bacterial biofilm production may play a role in modulating the effectiveness of PDI against Staphylococcus aureus.
  • Further research is warranted to understand the mechanisms of PDI and optimize its application against S. aureus infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...